Total Hip Arthroplasty Clinical Trial
— ProHipQ-FOfficial title:
The Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture: A Cross-over, Cluster Randomized Controlled, Non-inferiority Trial Based on National Quality Databases: ProHipQ-F
Aim: To compare the effect of one single dose versus multiple doses of prophylactic antibiotics administered within 24 hours, on the development of PJI after surgery in patients undergoing primary THA due to an acute fracture or sequelae of proximal femoral or acetabular fractures. The study is designed as a cross-over, cluster randomized, non-inferiority trial. All Danish orthopedic surgery departments performing primary THA with the majority being within inclusion criteria will be involved: Based on national quality databases, two-year cohorts of approximately 2,000 primary THAs due to a fracture or sequelae to a fracture, conducted at all public and private orthopedic departments in Denmark, this includes 36 sites corresponding to a total of 39 departments.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | July 1, 2025 |
Est. primary completion date | November 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients receiving a primary Total Hip Arthroplasty (THA) due to an acute- or sequelae of proximal femoral or acetabular fractures Exclusion Criteria: - Patients receiving a primary THA due to bone tumor or metastasis - Patients receiving a primary THA due to osteoarthritis and all reasons according to the Danish Hip Arthroplasty Register (DHR) except conditions mentioned in the inclusion criteria |
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Orthopedic Surgery, Aabenraa and Sønderborg, Hospital of Southern Jutland | Aabenraa | |
Denmark | Capio Private Hospital, Aalborg | Aalborg | |
Denmark | Department of Orthopedic Surgery, Aalborg, Aalborg University Hospital | Aalborg | |
Denmark | Aleris Private Hospital, Aarhus | Aarhus | |
Denmark | Deaprtment of Orthopaedic Surgery, Aarhus University Hospital | Aarhus | |
Denmark | Capio Private Hospital, Aarhus | Aarhus C | |
Denmark | Capio Private Hospital, Gildhøj | Brøndby | |
Denmark | Department of Orthopedic Surgery and Traumatology, Bispebjerg, Copenhagen University Hospital - Bispebjerg and Frederiksberg | Copenhagen NV | |
Denmark | Adeas Private Hospital, Parken | Copenhagen Ø | |
Denmark | Department of Orthopedic Surgery, Esbjerg, Hospital of South West Jutland | Esbjerg | |
Denmark | Department of Orthopedic Surgery, Farsø, Aalborg University Hospital | Farsø | |
Denmark | CPH Private Hospital | Farum | |
Denmark | Department of Orthopedic Surgery, Frederikshavn, Aalborg University Hospital | Frederikshavn | |
Denmark | Department of Orthopedic Surgery, Grindsted, Hospital of South West Jutland | Grindsted | |
Denmark | Capio Private Hospital, Hellerup and Odense | Hellerup | |
Denmark | Department of Orthopaedic Surgery, Gentofte, Copenhagen University Hospital - Herlev and Gentofte | Hellerup | |
Denmark | Department of Orthopaedic Surgery, Herlev, Copenhagen University Hospital - Herlev and Gentofte | Herlev | |
Denmark | Department of Orthopedic Surgery, Gødstrup Regional Hospital | Herning | |
Denmark | Department of Orthopedic Surgery, Hillerød, Copenhagen University Hospital - North Zealand | Hillerød | |
Denmark | Department of Orthopedic Surgery, Copenhagen University Hospital - Holbæk | Holbæk | |
Denmark | Department of Orthopedic Surgery, Horsens Regional Hospital, Denmark | Horsens | |
Denmark | Department of Orthopedic Surgery, Hvidovre, Copenhagen University Hospital - Amager and Hvidovre | Hvidovre | |
Denmark | Department of Orthopedic Surgery, Zealand University Hospital, Køge | Køge | |
Denmark | Acure Private Hospital | Kongens Lyngby | |
Denmark | Kollund Private Hospital, Kollund | Kruså | |
Denmark | Department for Planned Orthopaedic Surgery, Næstved, Copenhagen University Hospital - Næstved, Slagelse and Ringsted | Næstved | |
Denmark | Department of Orthopedic Surgery, Copenahegn University Hospital - Nykøbing F. | Nykøbing Falster | |
Denmark | Department of Orthopedic Surgery and Traumatology, Odense University Hospital and Svendborg Hospital | Odense | |
Denmark | Deparmtent of Orthopedic Surgery, Randers Regional Hospital | Randers | |
Denmark | Aleris Private Hospital, Ringsted | Ringsted | |
Denmark | Department of Surgery, Copenhagen University Hospital - Bornholm | Rønne | |
Denmark | Center for Planned Surgery, Silkeborg Regional Hospital | Silkeborg | |
Denmark | Aleris Private Hospital, Søborg | Søborg | |
Denmark | Department of Orthopedics, Lillebaelt Hospital, Vejle | Vejle | |
Denmark | Mølholm Private Hospital, Vejle | Vejle | |
Denmark | Deparmtent of Orthopedic Sugery, Viborg Regional Hospital | Viborg |
Lead Sponsor | Collaborator |
---|---|
Soren Overgaard | Aarhus University Hospital, Odense University Hospital, Sygehus Lillebaelt, University Hospital Bispebjerg and Frederiksberg, University of Aarhus, University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Incremental cost-effectiveness | The incremental cost-effectiveness will be calculated based on the costs per patient in the two antibiotic practices. Costs related to antibiotic prophylaxis, hospital admissions and readmissions, hospital outpatient visits, visits to General practitioner and costs related to sick leave from work will be included.
Data will be collected from: The Danish National Patient Registry (DNPR) The Civil Registration System (CRS) The Danish Agency for Labor Market and Recruitment registry STAR |
Within 90 days from index surgery | |
Other | Rate of revision after THA | Revision surgery is defined as a new surgical intervention the first time after the primary intervention including debridement alone or in combination with complete or partial removal or exchange of the implant. Revision due to any cause including PJI and aseptic loosening are included.
Revision risk is recorded from DHR and DNPR. |
Within 1 year from index surgery | |
Other | Mortality rate after index surgery | 1-year mortality rate is defined by date of death due to any cause after index surgery. Data is collected from The Civil Registration System (CRS). | Within 1 year from index surgery | |
Other | Incidence of Superficial incisional Surgical Site Infection | To be defined | Within 90 days from index surgery | |
Primary | Incidence of Prosthetic joint infections (PJI) | The definition of PJI is based on revision surgery. Revision surgery is defined as a new surgical intervention the first time after the primary intervention including debridement alone or in combination with complete or partial removal or exchange of the implant.
The definition of PJI is based on revision surgery. Revision surgery is defined as a new surgical intervention the first time after the primary intervention including debridement alone or in combination with complete or partial removal or exchange of the implant. Two or more intraoperative deep-tissue samples of phenotypically indistinguishable bacteria isolated from at least 3 deep-tissue samples One or more positive intraoperative samples from a closed fluid aspirate AND a biopsy (fluid AND tissue) of phenotypically indistinguishable bacteria isolated A PJI when an indication of deep infection is reported to The Danish Hip Arthroplasty Registry (DHR) by the surgeon upon revision surgery |
Within 90 days from index surgery | |
Secondary | Number of patients with one or more Serious Adverse Events (SAEs) | SAEs are defined according to the ICH-GCP guidelines. SAE refers to an event involving a significant risk of death or disability of the patient (or their offspring), including, but not limited to, an event that:
results in death is life-threatening - in the investigator's opinion the patient was in immediate risk of death from the adverse event when it appeared requires hospitalization or prolongs existing hospitalization results in permanent or significant disability is a congenital anomaly SAEs are recorded from The Danish National Patient Registry (DNPR). |
Within 90 days from index surgery | |
Secondary | Incidence of Potential PJI referred to as PJI-likely | PJI-likely is defined as at least one of the two criteria:
One single intraoperatively obtained positive culture (aspiration fluid OR tissue biopsy) regardless of microorganism One single positive culture obtained from aspiration of synovial fluid regardless of microorganism AND any antibiotic prescriptions (ATC category J01) redeemed |
Within 90 days from index surgery | |
Secondary | Length of hospital stay (LOS) | LOS defined as number of postoperative overnight stays, including transferals to other departments and hospitals. Data on LOS is acquired from DNPR. | Within 90 days from index surgery | |
Secondary | Incidence of Thromboembolic complications incl VTE, MI, AF, stroke | VTE is defined a priori as both deep venous thromboembolisms confirmed by compression ultrasound and pulmonary embolism confirmed by spiral computed tomography (CT), ventilation-perfusion scintigraphy or pathological removal of an embolus and based on the following diagnostic ICD10 codes: I26, I80.1-I80.9, I82.1-I82.9, or T81.7B-D. Data will be extracted from DNPR. | Within 90 days from index surgery | |
Secondary | Hospital-treated infections (excluding Surgical Site infections) | Any Hospital-treated infection is defined as any first-time hospital admission with a primary or secondary infection diagnosis after discharge from index THA surgery. Hospital-treated infections are identified from DNPR.
The list of infections includes chronic and more rare infections, to detect possible flare-up in any possible ongoing infections. The list will exclude urinary tract infections (UTI) due to a high risk of different registration praxis registration for UTI among hospitals in Denmark. |
Within 90 days from index surgery | |
Secondary | Proportion of patients with at least one dispensing for antibiotic | Community-based antibiotic use (any community-treated infection or antibiotic use after discharge) is defined as at least one dispensing after discharge from index THA surgery within 90 days for narrow- and broad-spectrum antibiotics based on the Anatomical Therapeutic Chemical classification (ATC) codes. All antibiotics in Denmark require prescriptions from a physician. The Danish National Health Service Prescription Database has registered all reimbursed prescriptions from all community pharmacies since 2004. Medications are coded according to the following ATC codes: J01CE, J01CF, J01DB, J01DC, J01DD, J01DE, J01DH, J01DI, J01CR, J01CA, J01F. J01E, J01MA ,J01AA | Within 90 days from index surgery | |
Secondary | Proportion of patients with a least one dispensing for opioids | Prescriptions redeemed is defined as at least 1 prescription dispensing of any opioid. Prescriptions of analgesics will be identified through The Danish National Prescription Registry. The registry contains information on all prescriptions redeemed by Danish residents in community pharmacies since 1995 (excluding hospital dispensaries). Information on Anatomical Classification System (ATC) codes and dispensation date will be applied to identify opioids. Following ATC codes (including all sub codes) are included: N01AH (opioid anesthetics), N02A (opioids), N07BC02 (methadone), and R05DA04 (codeine). Duration of treatment will be calculated based on no. of packages and volume. | Within 90 days from index surgery | |
Secondary | Proportion of patients with dispensing for acetaminophen or non-steroid anti-inflammatory drug | Prescription redeemed is defined as at least 1 prescription dispensing of any acetaminophen or NSAID within 90 days after index THA surgery. Prescriptions of analgesics are identified using the Danish National Prescription Registry. Information on Anatomical Classification System (ATC) codes and dispensation date will be applied to identify acetaminophen and NSAID. Following ATC codes (including all sub codes) are included M01A (NSAIDs). Duration of treatment will be calculated based on no. of packages and volume. | Within 90 days from index surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02818894 -
Spinal Anesthesia in Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT02242201 -
Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular
|
Phase 4 | |
Completed |
NCT02414542 -
Minima Clinical Study
|
||
Completed |
NCT01817010 -
Strength and Function Following Total Hip Arthroplasty
|
N/A | |
Completed |
NCT01443975 -
Clinical Evaluation on the Use of the X-pander Device
|
N/A | |
Recruiting |
NCT05530551 -
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
|
N/A | |
Recruiting |
NCT06141928 -
Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT05054192 -
Reliability and Validity of Modified Four Square Step Test
|
||
Recruiting |
NCT04492462 -
The Impact of Two Different Physical Therapy Programs in the Rehabilitation of Patients Undergoing Anterior Approach Hip Replacement Surgery
|
N/A | |
Withdrawn |
NCT02926651 -
Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty
|
Phase 4 | |
Completed |
NCT02308813 -
Predictability of the Ability to Perform an Emergency Stop With Disorders of the Hip
|
N/A | |
Recruiting |
NCT02032017 -
Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.
|
N/A | |
Recruiting |
NCT01312077 -
The Analgesic Efficacy of Periarticular Infiltration of Local Anaesthetic for Total Hip Replacement
|
Phase 4 | |
Withdrawn |
NCT01380665 -
Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty
|
Phase 4 | |
Recruiting |
NCT05893563 -
Corail Stability at 5-Years Post-Total Hip Arthroplasty
|
||
Recruiting |
NCT06088069 -
Effect of Virtual Reality on Perioperative Anxiety, Stress and Pain in Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT03210844 -
The Clinical Outcomes After Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT04801680 -
Mpact 3D Metal Cup PMS
|
||
Terminated |
NCT02006251 -
Real-Time Instrument for Acetabular Shell Positioning
|
||
Completed |
NCT01525667 -
Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty
|
Phase 1/Phase 2 |